Granahan Investment Management’s Genomic Health, Inc. GHDX Stock Holding History

Granahan Investment Management’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-115,880	Closed	-$7.86M	–	192
2019 Q3	$7.86M	Buy	115,880 +5,191	+5%	+$356K	0.43%	66
2019 Q2	$6.44M	Sell	110,689 -7,193	-6%	-$426K	0.32%	76
2019 Q1	$8.26M	Sell	117,882 -12,768	-10%	-$947K	0.44%	66
2018 Q4	$8.41M	Buy	130,650 +124,050	+1,880%	+$8.7M	0.6%	61
2018 Q3	$463K	Buy	+6,600	New	+$386K	0.03%	189

Granahan Investment Management's GHDX Position: Q4 2019 in Review

Granahan Investment Management sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 115,880 shares — an estimated $7.86M sold.

Granahan Investment Management first reported a position in GHDX in Q3 2018 and held it in 5 quarters. The position peaked at $8.41M in Q4 2018. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

Granahan Investment Management reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
Granahan Investment Management sold 115,880 Genomic Health, Inc. shares in Q4 2019, an estimated $7.86M.
Granahan Investment Management first reported a position in Genomic Health, Inc. in Q3 2018 and held it in 5 quarters.
Granahan Investment Management's Genomic Health, Inc. position peaked at $8.41M in Q4 2018.
0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on Granahan Investment Management's 13F filing for Q4 2019, filed 14 Feb 2020.